HughStoate90988 at 07:32, 10 April 2026

2026-04-10T07:32:41Z

New page

{{Short description|Indian Pharmaceutical company}}
{{Use dmy dates|date=May 2025}}
{{Use Indian English|date=May 2025}}
{{infobox company
| name = Troikaa Pharmaceuticals Ltd.
| logo = Troikaa Pharmaceuticals Logo.jpg
| caption =
| type = [[Privately held company|Private]]
| genre =
| fate =
| predecessor =
| successor =
| foundation = 1983
| founder = Mr. Rajni V. Patel
| defunct =
| location_city = [[Ahmedabad]], [[Gujarat]]
| location_country = [[India]]
| location =
| locations =
| area_served = Worldwide
| key_people = *Dr. Ketan R. Patel (Chairman & managing director)
*Mr. Milan R. Patel (Joint Managing Director)
|industry = [[Pharmaceutical industry|Pharmaceuticals]]
|products = [[Pharmaceutical]]s, Branded and [[Generic drug]]s,
| services =
| revenue =
| operating_income =
| net_income =
| aum =
| assets =
| equity =
| owner =
| num_employees = 2300+ (2019)
| parent =
| divisions =
| subsid =
| homepage = {{URL|http://www.troikaa.com}}
}}
'''Troikaa Pharmaceuticals''' is an Indian multinational pharmaceutical company headquartered in [[Ahmedabad]] city of [[Gujarat]], India.<ref>{{cite web |title=National Technology Day Celebration |url=http://pib.nic.in/newsite/mbErel.aspx?relid=121547 |website=pib.nic.in}}</ref> It is a public unlisted company and is classified as company limited by shares.<ref>{{cite news |last1=Das |first1=Sohini |title=Drug cos bet on NDDS for better price, market share |url=https://www.business-standard.com/article/companies/drug-cos-bet-on-ndds-for-better-price-market-share-114100101320_1.html |work=Business Standard India |date=1 October 2014 |access-date=19 October 2023 |archive-date=17 June 2019 |archive-url=https://web.archive.org/web/20190617053805/https://www.business-standard.com/article/companies/drug-cos-bet-on-ndds-for-better-price-market-share-114100101320_1.html |url-status=live }}</ref><ref>{{cite web |title=Troikaa's Dynapar QPS bags National Award |url=http://www.expressbpd.com/pharma/pharma-life/troikaas-dynapar-qps-bags-national-award-2/82613/ |website=BPD |date=10 June 2015 |access-date=19 October 2023 |archive-date=17 June 2019 |archive-url=https://web.archive.org/web/20190617053807/http://www.expressbpd.com/pharma/pharma-life/troikaas-dynapar-qps-bags-national-award-2/82613/ |url-status=live }}</ref>

== History ==
Troikaa Pharmaceuticals limited was established in 1983 in [[Ahmedabad]], [[Gujarat]] by Rajni V. Patel, one of the few pharmacy graduates, of the first batch of L. M. College of Pharmacy, Ahmedabad in 1950. Ketan Patel is the current Chairman & Managing Director of the company. According to article, he was named as "India’s pain killer" for inventing world's first painless diclofenac injection, which helps alleviate acute pain and inflammation. Milan R. Patel is Joint Managing Director of the company.

In May 2020, Troikaa received US Patent for one of its products 'Dynapar QPS'.<ref>{{cite web |title=Troikaa Pharma receives U.S. patent for Dynapar QPS |url=https://www.thehindu.com/business/troikaa-pharma-receives-us-patent-for-dynapar-qps/article31644286.ece |website=The Hindu |language=en-IN |date=21 May 2020 |access-date=19 October 2023 |archive-date=12 June 2020 |archive-url=https://web.archive.org/web/20200612103800/https://www.thehindu.com/business/troikaa-pharma-receives-us-patent-for-dynapar-qps/article31644286.ece |url-status=live }}</ref>

== Operations ==
Troikaa has three manufacturing facilities in [[Gujarat]] and [[Uttarakhand]] certified by ISO 9001:2000 and WHO GMP ([[The World Health Organization]] for following [[Good Manufacturing Practices]]). Company has six marketing divisions & strength of more than 2300 employees. Company has presence in more than 70 countries.<ref name='BS1'>{{cite web |last1=Reporter |first1=B. S. |title=Troikaa Pharma gets patent approval for Dynapar AQ in CIS |url=https://www.business-standard.com/article/companies/troikaa-pharma-gets-patent-approval-for-dynapar-aq-in-cis-110091300033_1.html |website=Business Standard India |date=13 September 2010 |access-date=19 October 2023 |archive-date=17 May 2021 |archive-url=https://web.archive.org/web/20210517102709/https://www.business-standard.com/article/companies/troikaa-pharma-gets-patent-approval-for-dynapar-aq-in-cis-110091300033_1.html |url-status=live }}</ref>

Troikaa secures its innovations related to Novel Drug Delivery systems through Patent co-operation treaty in more than 100 countries of the world.<ref name='BS'>{{cite web |last1=Reporter |first1=B. S. |title=Troikaa Pharma commences work on Sanand plant; to make Dynapar |url=https://www.business-standard.com/article/companies/troikaa-pharma-commences-work-on-sanand-plant-to-make-dynapar-115052201828_1.html |website=Business Standard India |date=22 May 2015 |access-date=19 October 2023 |archive-date=30 August 2019 |archive-url=https://web.archive.org/web/20190830094152/https://www.business-standard.com/article/companies/troikaa-pharma-commences-work-on-sanand-plant-to-make-dynapar-115052201828_1.html |url-status=live }}</ref><ref>{{cite news |last1=Reporter |first1=B. S. |title=Troikaa gets Australian patent for Dynapar AQ |url=https://www.business-standard.com/article/companies/troikaa-gets-australian-patent-for-dynapar-aq-109120200034_1.html |work=Business Standard India |date=2 December 2009 |access-date=19 October 2023 |archive-date=30 August 2019 |archive-url=https://web.archive.org/web/20190830095648/https://www.business-standard.com/article/companies/troikaa-gets-australian-patent-for-dynapar-aq-109120200034_1.html |url-status=live }}</ref>

== Litigation ==
In 2016, Troikaa Pharmaceuticals filed petition in [[Delhi High Court]] seeking license cancellation of Diclofenac Sodium Injection 75 mg/ml, manufactured by Themis Medicare Pvt Ltd and marketed by [[Novartis]] India Ltd. under the brand name Voveran 1ml.<ref>{{cite news |last1=Raghavan |first1=Prabha |title=Indian pharma company may sue drug controller over safety of Novartis painkiller |url=https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-pharma-company-may-sue-drug-controller-over-safety-of-novartis-painkiller/articleshow/52347842.cms |work=The Economic Times |date=19 May 2016 |access-date=19 October 2023 |archive-date=1 August 2017 |archive-url=https://web.archive.org/web/20170801172444/http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-pharma-company-may-sue-drug-controller-over-safety-of-novartis-painkiller/articleshow/52347842.cms |url-status=live }}</ref><ref>{{cite news |last1=Thacker |first1=Teena |title=Drug regulator orders recall of Novartis's painkiller diclofenac |url=https://www.livemint.com/Companies/Pq4oCrhPUFB2kdRbHsUrvK/Drug-regulator-orders-recall-of-Novartiss-painkiller-diclof.html |work=livemint.com |date=11 July 2018 |language=en |access-date=19 October 2023 |archive-date=13 August 2022 |archive-url=https://web.archive.org/web/20220813122633/https://www.livemint.com/Companies/Pq4oCrhPUFB2kdRbHsUrvK/Drug-regulator-orders-recall-of-Novartiss-painkiller-diclof.html |url-status=live }}</ref>

Troikaa Pharmaceuticals claimed that the diclofenac sodium 75 mg/ml injection contained Transcutol-P which caused damage to the kidneys.
In July 2018, [[Drug Controller General of India|India's Drug Regulator]] canceled the license granted to M/S Themis Medicare for the sale of Diclofenac injection 75 mg/ml containing Transcutol-P.<ref>{{cite news |last1=India |first1=Press Trust of |title=Drug regulator cancels licence for Diclofenac sold by Novartis |url=https://www.business-standard.com/article/pti-stories/drug-regulator-cancels-licence-for-diclofenac-sold-by-novartis-118071201086_1.html |work=Business Standard India |date=12 July 2018 |access-date=19 October 2023 |archive-date=17 June 2019 |archive-url=https://web.archive.org/web/20190617053859/https://www.business-standard.com/article/pti-stories/drug-regulator-cancels-licence-for-diclofenac-sold-by-novartis-118071201086_1.html |url-status=live }}</ref><ref>{{cite web |title='Novartis, Themis use unsafe ingredient' - BUSINESS & ECONOMY - News {{!}} News Syndication {{!}} Content Syndication |url=http://dnasyndication.com/showarticlerss.aspx?nid=cTYEU4Rp2ShYzJIeEsIuOKYUHBszQF6KtdBhRSYFvV4= |website=dnasyndication.com |access-date=2023-10-19 |archive-date=2023-10-20 |archive-url=https://web.archive.org/web/20231020100111/https://dnasyndication.com/ |url-status=live }}</ref>

In 2012, Troikaa Pharmaceuticals suits a patent infringement in Ahmedabad district court against Ahmedabad-based [[Lincoln Pharmaceuticals]] and Delhi-based [[Akums Drugs and Pharmaceuticals|Akums Drug & Pharmaceuticals Ltd]], saying the two companies had infringed upon its patented high concentration, low viscosity diclofenac injection. The case was continued by [[Gujarat High Court]] and ordered to Akums Drugs not to infringe as per the patent specification and dismissed Lincoln Pharma's appeal.<ref>{{cite news |last1=Dutta |first1=Vishal |title=HC grants relief to Troikaa in patent case; restrains two firms from selling Dynapar injections |url=https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hc-grants-relief-to-troikaa-in-patent-case-restrains-two-firms-from-selling-dynapar-injections/articleshow/12934339.cms?from=mdr |work=The Economic Times |date=30 April 2012 |access-date=19 October 2023 |archive-date=20 October 2023 |archive-url=https://web.archive.org/web/20231020100111/https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hc-grants-relief-to-troikaa-in-patent-case-restrains-two-firms-from-selling-dynapar-injections/articleshow/12934339.cms?from=mdr |url-status=live }}</ref>

In 2008, Troikaa filed a suit for infringement of design against a company manufacturing D’ shaped tablets. The company had challenged that Troikaa's D-shaped tablet registration was invalid. The suit was transferred to the [[High Court of Gujarat]] and later in its first case under the Designs Act, the High Court decided in favor of the Troikaa.<ref>{{cite web |last1=Reddy |first1=Prashant |title=Gujarat High Court grants interim injunction in Designs Case |url=https://spicyip.com/2008/08/gujarat-high-court-grants-interim.html |website=SpicyIP |date=11 August 2008 |access-date=2023-10-19 |archive-date=2021-01-31 |archive-url=https://web.archive.org/web/20210131132045/https://spicyip.com/2008/08/gujarat-high-court-grants-interim.html |url-status=live }}</ref>

== Awards & honors ==
*"The national award for R&D 2015" for "Dynapar QPS" by [[Ministry of Science and Technology (India)]] in [[Vigyan Bhavan]], New Delhi.<ref>{{cite web |title=Technology Development Board 20th Annual Report 2015-16 |url=http://tdb.gov.in/wp-content/uploads/2016/11/Annual-Report-2015-16.pdf |website=tdb.gov.in |publisher=Govet of India |access-date=2023-10-19 |archive-date=2022-07-09 |archive-url=https://web.archive.org/web/20220709060901/http://tdb.gov.in/wp-content/uploads/2016/11/Annual-Report-2015-16.pdf |url-status=live }}</ref><ref>{{cite web |title=National Technology Day Celebration |url=http://pib.nic.in/newsite/PrintRelease.aspx?relid=121547 |website=pib.nic.in |access-date=2023-10-19 |archive-date=2016-08-20 |archive-url=https://web.archive.org/web/20160820033924/http://pib.nic.in/newsite/PrintRelease.aspx?relid=121547 |url-status=live }}</ref><ref name='BS'/>
*"India Pharma Innovation of the Year Award" 2018 by Shri [[Ananth Kumar]], [[Ministry of Chemicals and Fertilizers|Union Minister of Chemicals and Fertilizers]], [[Government of India]]<ref>{{cite web |title=Troikaa bags recognition from Govt of India |url=http://www.expressbpd.com/pharma/latest-updates/troikaa-bags-recognition-from-govt-of-india/398219/ |website=BPD |date=1 March 2018 |access-date=19 October 2023 |archive-date=16 June 2019 |archive-url=https://web.archive.org/web/20190616053952/http://www.expressbpd.com/pharma/latest-updates/troikaa-bags-recognition-from-govt-of-india/398219/ |url-status=dead }}</ref>
*Intellectual Property Excellence in India Award 2016<ref>{{cite news |title=Troikaa wins award for IP Excellence |work=[[Daily News and Analysis]] |agency=Zee Media |date=12 Dec 2018 |location=Ahmedabad |page=4}}</ref>
*IPA ACG Scitech Innovation Awards 2015<ref>{{cite news |title=Troika receiving the IPA-ACG innovation in Solid Dosage form Award |issue=July 2015 |publisher=Pharma Times |date=7 July 2015 |location=Ahmedabad |page=9}}</ref>
*In 2008, National Award for R & D efforts in the area of Physical & Biological Sciences, for developing Dynapar AQ.<ref>{{cite web |title=DSIR : Department of Scientific and Industrial Research |url=http://www.dsir.gov.in/#files/tpdup/irdpp/award08.htm |website=www.dsir.gov.in |access-date=2023-10-19 |archive-date=2023-09-14 |archive-url=https://web.archive.org/web/20230914142150/http://www.dsir.gov.in/#files/tpdup/irdpp/award08.htm |url-status=live }}</ref>

== References ==
{{reflist}}

[[Category:Companies based in Ahmedabad]]
[[Category:Companies established in 1983]]
[[Category:Pharmaceutical companies of India]]

Troikaa Pharmaceuticals - Revision history

HughStoate90988 at 07:32, 10 April 2026